RiboX Therapeutics Receives FDA RMAT Designation for RXRG001 in Radiation-Induced Xerostomia RiboX Therapeutics, a clinical-stage biotechnology company focused on discovering and developing fully engineered circular RNA (circRNA) therapeutics, announced that…
Agilent Technologies Announces Board Leadership Transition and Appointment of Glenn Boehnlein Agilent Technologies Inc. (NYSE: A) has announced a series of leadership changes to its board of directors, marking an…
Compass Pathways to Highlight Treatment-Resistant Depression Research and Launch New HCP Education Campaign at Psych Congress 2026 Compass Pathways plc (Nasdaq: CMPS), a biotechnology company focused on developing new treatment…
Teleflex Appoints Sean M. Salmon to Board of Directors to Support Strategic Growth Teleflex Incorporated, a global provider of medical technologies, has announced the appointment of Sean M. Salmon to…
Alzheon Reports Biomarker Findings Supporting Potential Disease-Modifying Effects of Valiltramiprosate in Early Alzheimer’s Disease Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing investigational therapies and diagnostic assays for Alzheimer’s…
Dunbar Pharmaceuticals to Showcase Pharmaceutical-Grade Plant-Derived Dronabinol at expopharm 2026 Dunbar Pharmaceuticals, also known as Dunbar Pharma, is set to participate in expopharm 2026, one of Europe’s leading trade fairs…
GenSight Biologics Provides Summer 2026 Business and Clinical Development Updates GenSight Biologics, a biopharmaceutical company specializing in the development and commercialization of innovative gene therapies for retinal neurodegenerative diseases and…
Aptar Pharma and Aceso Therapeutics Collaborate to Advance Inhaled ASO Therapy for Cystic Fibrosis Aptar Pharma, a global provider of drug delivery, dosing, protection technologies and development services, has announced…
Agilent Launches S540MD Slide Scanner in the U.S. Following FDA Clearance Agilent Technologies Inc. has announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging…
Teleflex Highlights Advanced Vascular Technologies at CIRSE 2026, Featuring Dynetic™-35 Stent System Teleflex Incorporated, a global provider of medical technologies, is set to showcase a range of innovative solutions at…
Ionis Pharmaceuticals Receives FDA Approval for ZANVASTRO, First Disease-Modifying Treatment for Alexander Disease Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) has announced that the U.S. Food and Drug Administration (FDA) has approved…
Stoke Therapeutics and Biogen Present Long-Term Zorevunersen Data Supporting Potential Disease-Modifying Treatment for Dravet Syndrome Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company focused on restoring protein expression through RNA…